https://www.live-feeds.com/feed/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakersContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakershttps://www.live-feeds.com/feed/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakers#u60513Mon, 07 Sep 2026 20:46:47 +0000President Donald Trump secured drug pricing agreements with nine pharmaceutical companies, including Alcon Inc., Astellas Pharma, BeOne Medicines Ltd., BridgeBio, and CSL. These pacts aim to align U.S. drug costs with international prices and require lower pricing for state Medicaid programs. This expansion brings the total number of participating companies to 26. While the administration targets lower costs for Americans, analysts do not expect the agreements to meaningfully impact the profits of the participating drugmakers.Why it mattersThe administration previously reached similar deals wi https://www.live-feeds.com/feed/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakershttps://www.live-feeds.com/feed/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakers#u54052Tue, 01 Sep 2026 13:47:00 +0000The Trump administration has announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies. These deals require the companies to provide lower prices to state Medicaid programs nationally. The agreements build on previous deals struck with 17 of the world's largest drugmakers. The move is part of Trump's efforts to lower drug prices for Americans.Why it mattersThe Trump administration has been focusing on reducing drug prices, a key concern for many Americans. The new agreements aim to provide lower prices for Medicaid programs, which cou